No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
INCY240719C57500
- 6.00
- +2.63+78.04%
15min DelayClose Jul 12 16:00 ET
6.00High6.00Low
6.00Open3.37Pre Close1 Volume40 Open Interest57.50Strike Price600.00Turnover73.10%IV-0.25%PremiumJul 19, 2024Expiry Date6.16Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8735Delta0.0348Gamma9.65Leverage Ratio-0.1093Theta0.0080Rho8.43Eff Leverage0.0169Vega
Intraday
- 5D
- Daily
News
Form 144 | Incyte(INCY.US) Officer Proposes to Sell 488.88K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 9, $Incyte(INCY.US)$ Officer BARRY FLANNELLY intends to sell 8,148 shares of its common stock on Jul 9, with a total market value of approximately $488.88K. BARRY
S&P 500, Nasdaq Set New Closing Records After Fed Chair Powell's Comments
The S&P 500 and the Nasdaq Composite closed at new record highs Tuesday after Federal Reserve Chair Jerome Powell said inflation seems to have improved in recent months, though the job is not done
S&P 500 Hits Record Highs, Eyes 6th Straight Gain As Powell Keeps Bears At Bay; Tesla Targets 10th Consecutive Win, Bank Stocks Rally: What's Driving Markets Tuesday?
The S&P 500 index climbed to new all-time highs, rising 0.3% during Tuesday's session, aiming for a potential sixth consecutive positive close and remaining resilient after Fed Chair Jerome Powell's
Incyte to Report Second Quarter Financial Results
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its second quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, July 30, 202
Express News | Incyte Corp : RBC Raises Target Price to $61 From $60
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Incyte (NASDAQ:INCY) today announced that it granted restricted stock unit awards (RSUs) representing an aggregate of 14,577 shares of the Company's common stock and stock option awards to purchase an aggregate of
Comments
Morning Movers
Gapping up
$Paramount Global-B(PARA.US$ 's stock increased by 3.85% following a report from the New York Times that billionaire Barry Diller is considering a takeover bid for the company after the studio he used to lead withdrew from a merger with Skydance Media.
$PayPal(PYPL.US$ shares rose by 1.39% after Susquehanna raised its rating from Neutral to Positive.
Gapping down
$Tesla(TSLA.US$ 's stock declined ...
Gapping up
$Paramount Global-B(PARA.US$ 's stock increased by 3.85% following a report from the New York Times that billionaire Barry Diller is considering a takeover bid for the company after the studio he used to lead withdrew from a merger with Skydance Media.
$PayPal(PYPL.US$ shares rose by 1.39% after Susquehanna raised its rating from Neutral to Positive.
Gapping down
$Tesla(TSLA.US$ 's stock declined ...
30
2
I am currently a full-time NSF, and I have been investing in about 6-7 months.
I managed to garner an average of 3% a month the past 4 months using several methods of trading.
I started trading about 6 months ago with a small sum to test the waters until I was fully ready to begin my journey in March.
Trading is relatively simple if you just try to minimize your risk as much as possible and just throw that gambler's mindset into the bin...
I managed to garner an average of 3% a month the past 4 months using several methods of trading.
I started trading about 6 months ago with a small sum to test the waters until I was fully ready to begin my journey in March.
Trading is relatively simple if you just try to minimize your risk as much as possible and just throw that gambler's mindset into the bin...
+4
211
74
This month was a really chaotic month for me as it was very volatile with huge ups and downs.
My three biggest winners this month were INCY, APPL, and NVDA. Although my P/L could be higher if I did not sell my NVDA early, I still managed to reap the 5% gain in NVDA.
I believe NVDA holds massive growth potential as many companies have started shifting to NVDA, and AI hype will not seem to die down so soon. I will be expecting around 30 billion in revenue next quarter, which led me to buy ...
My three biggest winners this month were INCY, APPL, and NVDA. Although my P/L could be higher if I did not sell my NVDA early, I still managed to reap the 5% gain in NVDA.
I believe NVDA holds massive growth potential as many companies have started shifting to NVDA, and AI hype will not seem to die down so soon. I will be expecting around 30 billion in revenue next quarter, which led me to buy ...
11
5
This month was a really chaotic month for me as it was very volatile with huge ups and downs.
My three biggest winners this month were INCY, APPL, and NVDA. Although my P/L could be higher if I did not sell my NVDA early, I still managed to reap the 5% gain in NVDA.
I believe NVDA holds massive growth potential as many companies have started shifting to NVDA, and AI hype will not seem to die down so soon. I will be expecting around 30 billion in revenue next quarter, which led ...
My three biggest winners this month were INCY, APPL, and NVDA. Although my P/L could be higher if I did not sell my NVDA early, I still managed to reap the 5% gain in NVDA.
I believe NVDA holds massive growth potential as many companies have started shifting to NVDA, and AI hype will not seem to die down so soon. I will be expecting around 30 billion in revenue next quarter, which led ...
8
» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte(INCY.US$
$BeiGene(BGNE.US$
$ACADIA Pharmaceuticals(ACAD.US$
$Madrigal Pharmaceuticals(MDGL.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Revolution Medicines(RVMD.US$
$Kymera Therapeutics(KYMR.US$
$AbCellera Biologics(ABCL.US$
$Bicycle Therapeutics(BCYC.US$
$Edgewise Therapeutics(EWTX.US$
$Immunocore(IMCR.US$
$Kodiak Sciences(KOD.US$
$Roivant Sciences(ROIV.US$
...
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte(INCY.US$
$BeiGene(BGNE.US$
$ACADIA Pharmaceuticals(ACAD.US$
$Madrigal Pharmaceuticals(MDGL.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Revolution Medicines(RVMD.US$
$Kymera Therapeutics(KYMR.US$
$AbCellera Biologics(ABCL.US$
$Bicycle Therapeutics(BCYC.US$
$Edgewise Therapeutics(EWTX.US$
$Immunocore(IMCR.US$
$Kodiak Sciences(KOD.US$
$Roivant Sciences(ROIV.US$
...
7
Read more
Ivo Stoyanov : ..
raz1 : how do iset my chart to see gaps